Lead is absorbed following inhalation, oral, and dermal exposure. It is then distributed mainly to the bones and red blood cells. In the blood lead may be found bound to serum albumin or the metal-binding protein metallothionein. Organic lead is metabolized by cytochrome P-450 enzymes, whereas inorganic lead forms complexes with delta-aminolevulinic acid dehydratase. Lead is excreted mainly in the urine and faeces. (L136)
Lead mimics other biologically important metals, such as zinc, calcium, and iron, competing as cofactors for many of their respective enzymatic reactions. For example, lead has been shown to competitively inhibit calcium's binding of calmodulin, interferring with neurotransmitter release. It exhibits similar competitive inhibition at the NMDA receptor and protein kinase C, which impairs brain microvascular formation and function, as well as alters the blood-brain barrier. Lead also affects the nervous system by impairing regulation of dopamine synthesis and blocking evoked release of acetylcholine. However, it's main mechanism of action occurs by inhibiting delta-aminolevulinic acid dehydratase, an enzyme vital in the biosynthesis of heme, which is a necesssary cofactor of hemoglobin. (T4, A20, A22, L136)
There is limited evidence in humans for the carcinogenicity of inorganic lead compounds. ... There is sufficient evidence in experimental animals for the carcinogenicity of inorganic lead compounds. There is sufficient evidence in experimental animals for the carcinogenicity of lead acetate, lead subacetate, lead chromate, and lead phosphate. There is inadequate evidence in experimental animals for the carcinogenicity of lead oxide and lead arsenate. ... There is inadequate evidence in experimental animals for the carcinogenicity of lead powder. Overall evaluation Inorganic lead compounds are probably carcinogenic to humans (Group 2A). /Inorganic lead compounds/
CLASSIFICATION: B2; probable human carcinogen. BASIS FOR CLASSIFICATION: Sufficient animal evidence. Ten rat bioassays and one mouse assay have shown statisticlly significant increases in renal tumors with dietary and subcutaneous exposure to several soluble lead salts. Animal assays provide reproducible results in several laboratories, in multiple rat strains with some evidence of multiple tumor sites. Short term studies show that lead affects gene expression. Human evidence is inadequate. HUMAN CARCINOGENICITY DATA: Inadequate. ANIMAL CARCINOGENICITY DATA: Sufficient. /Lead and Compounds (inorganic), Based on former classification system/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
致癌性证据
A3; 对动物已确认是致癌物,但对人类的相关性未知。/铅,元素铅和无机铅化合物,如 Pb/
A3; Confirmed animal carcinogen with unknown relevance to humans. /Lead, elemental, and inorganic compounds, as Pb/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
致癌性证据
铅、铅化合物:合理预期为人类致癌物
Lead, lead compounds: Reasonably anticipated to be a human carcinogen
Absorption of lead from the GI tract in experimental animals is influenced by a number of factors, including age, level of food intake and form of food matrix, and chemical form of the lead. It is most probably a saturable process. With increasing dose in rats, 1-100 mg lead as lead acetate per kg bw, lead absorption was found to decrease as a percentage of dose, from 42 to 2%
... Different forms of lead and particle size have different rates of absorption in the rat. Carbonate and thallate were absorbed to the greatest extent, whereas absorption of sulfide, chromate, naphenate, and octoate were absorbed at only 44-67% the rate of absorption for lead acetate ... Uptake of lead into the femurs of rats was highest for lead acetate, intermediate for lead oxide, and lowest for lead sulfide and a mixture of Alaskan ore concentrate ... Lead mining waste soil was 8-20% as bioavailable as lead acetate.
There was a variation in lead levels in the nervous system of rats administered lead acetate 0.2% in drinking water for the first 8 mo of life in amounts localized in different regions of the brain. Lead levels were highest in the hippocampus and cerebral neocortex.
Lead is eliminated from the body by both urine and feces. Any dietary lead not absorbed is excreted in feces. Blood lead not retained in the body is excreted in urine or feces. Adults ingesting daily 0.3-3.0 mg lead (as lead acetate) in drinking water for 16-208 wk excreted more than 85% of the ingested lead; 90% of the lead was in the feces.
A catalytic homogeneous liquid phase process for effecting the acyloxylation of toluene to produce the corresponding benzylic ester. The catalyst system comprises Pd(II) and Pb(II) values wherein the palladous element component is associated with a catalytic amount of a tertiary phosphine as a complexed ligand. The indicated catalyst system uniquely facilitates the advantageous use of normally immiscible carboxylic acid reactants for carrying out the underlying benzylic oxidation reaction.
A process for preparing an N-alkylaminophenol is disclosed, comprising subjecting an aminophenol to reductive alkylation with an aldehyde or a ketone in the presence of an organic solvent and hydrogen, wherein the reductive alkylation is carried out at a temperature of from 20.degree. to 70.degree. C. in the further presence of a catalyst for reduction comprising platinum and at least one metal element selected from metal elements belonging to the IB group, IIB group, IVB group, VB group, and VIB group of the Periodic Table, supported on activated carbon, or comprising palladium and at least one metal element selected from metal elements belonging to the IB group, IIB group, IVB group, VB group and VIB group of the Periodic Table, supported on activated carbon.
The present invention is directed to compounds of the formula ##STR1## wherein R.sub.1 is lower alkyl and R.sub.2 is lower alkyl or aryl. Also provided are methods for preparation of these compounds. The compounds of formula I above are useful as plant growth regulants.
Method for fabricating ferro-electric thin films using a sol-gel technique
申请人:Interuniversitair Micro-Elektronica Centrum (IMEC vzw)
公开号:US20020008227A1
公开(公告)日:2002-01-24
A method is disclosed for the formation of ferro-electric films using a multi coating process based on a sol-gel technique. In particular a method is disclosed to fabricate high-quality thickness scaled PZT films of an alkoxide-type liquid chemical PZT precursor solution, preferably a Pb(Zr
x
Ti
1−x
)O
3
precursor solution, using a sol-gel technique. At least two coated layers are deposited, but the precise number of coated layers depends on the desired thickness of the ferro-electric film. According to the method of the invention, the electrical characteristics of the film as formed are not dependent on the number of coated layers. There are a number of properties, characteristic for the method of the present invention, and resulting in said excellent electrical characteristics. In fact said method can comprise a multi coating process wherein a reduced number of coated layers is used but where intermediate crystallization steps are performed. The ferro-electric films formed using this method have excellent electrical characteristics, provided that a crystallization step is only performed if the thickness of the film formed since the last crystallization step is minimum about 40 to 50 nm. Alternatively, the method can comprise a multi coating process wherein no intermediate crystallization steps are used.
Production of lead monoxide from lead sulfate with acidic ammonium
申请人:N L Industries, Inc.
公开号:US04220628A1
公开(公告)日:1980-09-02
An efficient and inexpensive method for producing lead monoxide from impure lead sulfate bearing materials such as recycled battery mud is provided comprising: (a) reacting said material with an ammonium carbonate solution to convert lead sulfate to lead carbonate; (b) decomposing the lead carbonate to produce impure lead monoxide; (c) reacting said impure lead monoxide with an acidic ammonium acetate solution to form a lead acetate solution; (d) reacting ammonium hydroxide with the lead acetate solution to form lead hydroxide; and (e) dehydrating the lead hydroxide to produce lead monoxide.